Authors: Sharon Salt, Editor
During the early stages of Alzheimer’s disease (AD), it is known that there is a decrease in cerebral blood flow. This observation has led researchers to examine whether drugs that affect blood pressure could play a role at improving blood flow.
According to a recent study, which has been published in Hypertension, nilvadipine has been demonstrated to increase blood flow to the hippocampus among people with AD without affecting other parts of the brain. Researchers have also indicated that this decrease in blood flow in people with Alzheimer’s may be reversed in some regions of the brain. However, whether this observed increase in cerebral blood flow translates to clinical benefits is yet to be determined.